We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Federated Hermes Short Duration Corporate ETF
FCSH
$66.6M
| $22.6M | 0.07% |
990,004
| – | – |
|
352
CarGurus
CARG
$3.12B
| $22.5M | 0.07% |
1,589,532
+932,402
| +142% | +$18.9M |
|
353
Pegasystems
PEGA
$6.19B
| $22.5M | 0.07% |
1,398,638
+544,070
| +64% | +$11.1M |
|
354
Revolve Group
RVLV
$1.47B
| $22.4M | 0.07% |
1,033,332
-18,801
| -2% | -$495K |
|
355
Ingersoll Rand
IR
$27.9B
| $22.3M | 0.07% |
515,563
-527,679
| -51% | -$24.9M |
|
356
Cooper Companies
COO
$10.1B
| $22.1M | 0.06% |
335,044
-182,024
| -35% | -$13.9M |
|
357
Occidental Petroleum
OXY
$63.5B
| $22M | 0.06% |
358,568
-143,081
| -29% | -$9.16M |
|
358
Zimmer Biomet
ZBH
$18.8B
| $22M | 0.06% |
210,238
+32,995
| +19% | +$3.62M |
|
|
DCT
359
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $21.9M | 0.06% |
1,847,317
+1,762,055
| +2,067% | +$23.3M |
|
360
Analog Devices
ADI
$175B
| $21.8M | 0.06% |
156,613
-115,208
| -42% | -$18.2M |
|
361
GXO Logistics
GXO
$5.34B
| $21.7M | 0.06% |
618,374
-110,137
| -15% | -$4.86M |
|
362
Brighthouse Financial
BHF
$2.82B
| $21.6M | 0.06% |
496,793
+9,746
| +2% | +$444K |
|
363
Teradyne
TER
$52B
| $21.6M | 0.06% |
286,765
-34,385
| -11% | -$3.13M |
|
364
Federated Hermes Short Duration High Yield ETF
FHYS
$54.8M
| $21.5M | 0.06% |
994,000
| – | – |
|
|
SWAV
365
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $21.4M | 0.06% |
77,031
+70,655
| +1,108% | +$18M |
|
|
NVEI
366
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $21.4M | 0.06% |
790,000
| – | – |
|
367
Prothena Corp
PRTA
$428M
| $21.2M | 0.06% |
350,137
+345,634
| +7,676% | +$10.9M |
|
368
Immatics
IMTX
$1.31B
| $21.1M | 0.06% |
2,106,000
| – | – |
|
|
369
Keysight
KEYS
$53.3B
| $21M | 0.06% |
133,553
-450,249
| -77% | -$72.1M |
|
370
Power Integrations
POWI
$2.7B
| $20.9M | 0.06% |
325,123
-16,486
| -5% | -$1.23M |
|
371
MetLife
MET
$62.4B
| $20.8M | 0.06% |
342,920
+10,304
| +3% | +$658K |
|
372
AbCellera Biologics
ABCL
$3.7B
| $20.8M | 0.06% |
2,104,041
+367,822
| +21% | +$4.04M |
|
373
Tesla
TSLA
$1.41T
| $20.7M | 0.06% |
78,211
+7,414
| +10% | +$2.07M |
|
374
Atea Pharmaceuticals
AVIR
$419M
| $20.6M | 0.06% |
3,626,818
+38,687
| +1% | +$296K |
|
375
Revvity
RVTY
$15.6B
| $20.3M | 0.06% |
168,858
-6,582
| -4% | -$928K |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.